Social Media Influencers Driving Unofficial Trade for Unlicensed Weight-Loss Drug
An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Some experts stated the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.
Service Reaction and Content Elimination
Based on TikTok, the service has taken down violative content and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.
After moments of entering one community, a seller posted WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.
Product Information and Pricing
Within these groups, posts show black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially serious health risks”.